The purpose of this modification is to deobligate canceling year funds from requisition OS252049 in the amount of (-$1.16) from CLIN00002.

Ended Definitive Contract Awarded Last action

Contract number
75A50118C00013
Awardee
Awarding agency
Obligated
$62,626,467

Award facts

Contract value 89% obligated
  • $62,626,466.75 Current, with exercised options
  • $70,578,260.68 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Charlestown, MA 02129, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00012 -$1
Other Administrative Action P00011 · The purpose of this modification is to extend the period of performance for CLIN0006 option 2C through may 31, 2025, at no additional cost to the government due… $0
Other Administrative Action P00010 · The purpose of this modification is to DE-obligate canceling funds from requisition OS227565 in the amount of ($11,704.99), update sections f.2 deliverables,… -$11,705
Other Administrative Action P00009 · Statement of work to remove section 3.2 G1 MD $0
Other Administrative Action P00008 $0
Exercise an Option P00007 $5,676,127
Funding Only Action P00006 $4,061,564
Exercise an Option P00005 $7,993,147
Supplemental Agreement for work within scope P00004 $0
Exercise an Option P00003 $14,611,967
Exercise an Option P00002 · The purpose of this contract is to develop a rapid ID and phenotypic antibiotic susceptibility testing (AST) platform to accept direct from patient samples $9,613,244
Exercise an Option P00001 · Exercise option 1 $11,386,756
Original award $9,295,369
Show all 13

About this award

The Office of the Assistant Secretary for Preparedness and Response awarded a definitive contract to Selux Diagnostics, Inc. on September 24, 2018, with a ceiling value of $70.578 million under cost-plus-fixed-fee pricing for development of a rapid identification and phenotypic antibiotic susceptibility testing (AST) platform to accept direct patient samples.

Place of performance is Charlestown, MA. The contract ultimate completion date is May 31, 2025. No set-aside category applies.

The source documents a recent modification to deobligate $1.16 from fiscal year funds. Selux Diagnostics assembled a multi-vendor team including Beckman Coulter, Inc. for materials and equipment, Cubrc, Inc. for program management, Element Materials Technology Iowa City Inc. (JMI Laboratories) for clinical trial reference isolate testing, The Trustees of Columbia University in the City of New York for clinical trial performance, and additional subcontractors for manufacturing, non-clinical microbiology testing, consumables, and logistics support.

Subawards

Subcontractor Amount Awarded
Beckman Coulter, Inc. $792,000
Cubrc, Inc. $219,563
Element Materials Technology Iowa City Inc. $158,492
The Trustees Of Columbia University In The City Of New York $50,000
Analytichem Usa, Inc. $28,628
VWR International LLC $27,150
D & K Engineering $2,039,039
Element Materials Technology Boston-Acton Inc. $203,545
Sigma-Aldrich Corporation $25,000
Beckman Coulter, Inc. $1,256,100
Americanbio Inc. $50,483
Ups Supply Chain Solutions, Inc. $50,000
Show all 12

Quick answers

Who was awarded contract 75A50118C00013?

75A50118C00013 was awarded to Selux Diagnostics, Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 24, 2018.

How much is contract 75A50118C00013 worth?

The government has obligated $62,626,467 on 75A50118C00013. Its potential value, with all options, is $70,578,261.

Was contract 75A50118C00013 competed?

The extent of competition for 75A50118C00013 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award